5 Retrospective Risk Adjustment Platforms for Health Plans
When we compare the best risk adjustment software for health plans, we focus on retrospective chart review: how recommendations connect to evidence, who checks them, and what reaches submission.
These five picks cover software and technology-enabled services, with RAAPID first for evidence-focused review. Pricing visibility and contract scope also shape the comparison.
Key Takeaways
RAAPID is our top pick for evidence-linked recommendations and two-way review that weighs deletions equally with additions.
Datavant fits plans seeking first-pass coding and additional review levels.
Reveleer pairs chart excerpts and page references with coder confirmation.
Cotiviti offers two-way review and a coder-led second-level service.
Optum suits plans seeking retrospective, submission, and audit-support services.
How we picked these retrospective platforms
We reviewed official product pages as of October 9, 2026. This is desk research, not hands-on testing; rankings reflect documented fit rather than measured superiority.
We compared evidence traceability in Hierarchical Condition Category (HCC) coding, handling of missed and unsupported codes, human review, delivery options, submission support, Risk Adjustment Data Validation (RADV) audit tools, and public pricing. We distinguished in-house HCC coding from service-supported delivery.
For every vendor, integration details, data handling, included modules, model support, implementation responsibilities, and commercial terms need contractual confirmation.
Customer-case results are vendor-reported and not comparable across products.
RAAPID
RAAPID pros
HCC recommendations linked to supporting MEAT evidence
Two-way review adds supported codes and flags unsupported ones for deletion
RAAPID cons
No public pricing on the reviewed page
RADV audit tools sit in a separate solution, so scope needs confirming
Why we picked RAAPID
We rank RAAPID first for evidence-focused review because its documented recommendations give reviewers a direct link to supporting chart evidence.
We also like that it gives deletions the same weight as additions, with certified coders confirming every recommendation.
RAAPID reports 92% out-of-box AI accuracy, rising to over 98% after human quality review, based on its own client benchmarks.
For a closer look at how two-way review adds supported codes and removes unsupported ones, RAAPID’s guide to retrospective risk adjustment covers MEAT documentation and RADV readiness.
RAAPID pricing
Public pricing not listed on the reviewed page; request a scoped proposal. Confirm whether RADV audit tools are included so the proposal reflects your needs. A demo does not establish a free trial.
Datavant
Datavant pros
First-pass coding plus second- and third-level review
Tiered quality audits alongside coder review
Datavant cons
Retrieval, coding, and data-platform scope need explicit definition
Public list pricing is not established
Why we picked Datavant
We picked Datavant for plans needing several review stages for new and previously coded charts. Its documented first-pass, second-level, and third-level options give procurement teams a concrete way to specify review depth.
Health Data Nexus offers searchable, indexed records across a member population, but buyers should confirm its inclusion rather than assume it comes with coding.
Datavant pricing
Public pricing not listed on the reviewed page; request a scoped proposal.
Specify retrieval, review levels, quality assurance, and any data-platform components, with responsibilities for each stage. The contact page does not establish tiers or free usage limits.
Reveleer
Reveleer pros
EVE recommendations include chart excerpts and page references
A coder confirms each code
Reveleer cons
Coder staffing and responsibilities need confirmation
GenECS must fit AI policies; non-generative ECS is available when contracts bar generative AI
Why we picked Reveleer
We picked Reveleer for its evidence-linked recommendations and explicit coder-confirmation step. Its retrospective page cites 1.2 million charts coded in 4 months in a vendor-reported regional health-plan case, a single engagement rather than a promised timeline.
Keep retrospective review separate from its RADV Audit SaaS Solution, announced October 15, 2025, whose self-service, managed, and hybrid options describe delivery approaches rather than subscription tiers.
Reveleer pricing
Public pricing not listed on the reviewed page; request a scoped proposal.
Confirm retrospective, retrieval, and RADV scope, along with the contracted AI configuration. A demo request does not establish a free tier.
Cotiviti
Cotiviti pros
Two-way review highlights additions and deletions
Second Level Review has expert coders validate 100% of NLP findings
Cotiviti cons
Platform and service offerings need separate scope confirmation
Public pricing is not established on the reviewed pages
Why we picked Cotiviti
We picked Cotiviti for plans seeking coding technology with an additional coder-led validation layer.
Its two-way review addresses additions and deletions, such as a dementia diagnosis carried forward without current supporting evidence, while its statement that coders validate every finding describes process coverage, not perfect accuracy.
Cotiviti says it works with more than 200 healthcare organizations, a company-wide figure rather than a retrospective-product customer count.
Cotiviti pricing
Public pricing not listed on the reviewed page; request a scoped proposal.
Ask which retrieval, platform, and second-level services are included, who supplies coders, and how responsibilities are divided.
Optum
Optum pros
Submission management covers error handling and remediation
Customizable audit-support services
Optum cons
Broader services portfolio, without published standalone coding-seat prices
Audit-support boundaries and fees require clarification
Why we picked Optum
We picked Optum for plans seeking operational support across several retrospective stages, including submissions.
Its retrospective page describes submission management and remediation, while its Submission Services page says clients can drive error correction through a portal.
Audit services are customizable, so buyers should scope them separately from coding and establish who handles each handoff between internal staff and vendor teams.
Optum pricing
Public pricing not listed on the reviewed page; request a scoped proposal. Separate coding, submission, remediation, and audit-support costs to clarify the quote.
The reviewed page does not establish standardized software tiers or free usage allowances.
Conclusion
RAAPID is our top pick for evidence-focused retrospective review with two-way coding. Datavant fits layered coding review; Reveleer fits excerpt-based coder workflows.
Cotiviti and Optum merit consideration when additional review services or submission support drive the purchase.
A source-linked suggestion still needs clinical and eligibility review; no platform guarantees compliance, audit success, or reimbursement.
Ask shortlisted vendors to work through the same approved, de-identified sample, showing a supported addition, an unsupported-code correction, the evidence behind each, and the services included in the proposal.
